Internal Medicine, Pulmonary Disease · Olympia, WA
NPI
1114192937
Since 2008
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
500 Lilly Road NE, Suite 201
Olympia, WA, 98506
Phone (360) 413-8272
Groups this clinician bills Medicare through
Medicare paid, 2024
$162K
4,595 services
Medicare patients, 2024
733
Average age 75
Drug cost, 2024
$3.8M
8,318 prescriptions
Company payments, 2025
$165
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Richard C Redman was code 99213 (office e&m - established), 417 times for 347 patients. In total Richard C Redman billed 4,595 services in 54 codes, and Medicare paid $162K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-05-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 417 | 347 | $63.31 | $26K |
| 99214 Office E&M - Established | Office | 333 | 258 | $89.06 | $30K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 305 | 266 | $12.61 | $3,845 |
| 94726 Pulmonary Function Testing | Office | 166 | 158 | $40.63 | $6,744 |
| 94729 Pulmonary Function Testing | Office | 165 | 157 | $40.94 | $6,755 |
| 99291 Critical Care E&M | Facility | 128 | 49 | $162.51 | $21K |
| 94618 Pulmonary Function Testing | Office | 109 | 107 | $25.17 | $2,743 |
| 94010 Pulmonary Function Testing | Office | 102 | 99 | $19.84 | $2,024 |
| 99204 Office E&M - New | Office | 92 | 92 | $121.53 | $11K |
| 99233 Hospital E&M - Subsequent | Facility | 90 | 39 | $91.22 | $8,210 |
| 99232 Hospital E&M - Subsequent | Facility | 77 | 35 | $60.87 | $4,687 |
| 94060 Pulmonary Function Testing | Office | 72 | 69 | $28.74 | $2,069 |
| 31624 Bronchoscopy | Facility | 59 | 58 | $7.83 | $462 |
| 94726 Pulmonary Function Testing | Facility | 48 | 48 | $8.43 | $404 |
| 94729 Pulmonary Function Testing | Facility | 48 | 48 | $6.37 | $306 |
By year: 2022 $212K for 3,355 services; 2023 $185K for 4,254 services; 2024 $162K for 4,595 services.
Medicare prescription drug claims, 2024
In 2024, the drug Richard C Redman prescribed most often to Medicare patients was Albuterol Sulfate Hfa (Albuterol Sulfate), with 1,066 prescriptions and refills. In total Richard C Redman wrote 8,318 Medicare prescriptions that cost $3.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Albuterol Sulfate Hfa Albuterol Sulfate | 1,066 | 1,283 | 318 | $33K |
| Prednisone Generic | 814 | 1,030 | 324 | $5,230 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 701 | 873 | 118 | $552K |
| Azithromycin Generic | 603 | 755 | 207 | $7,423 |
| Montelukast Sodium Generic | 413 | 812 | 91 | $5,341 |
| Stiolto Respimat Tiotropium Br/Olodaterol Hcl | 365 | 516 | 79 | $234K |
| Omeprazole Generic | 294 | 492 | 71 | $3,972 |
| Famotidine Generic | 253 | 398 | 55 | $2,684 |
| Ventolin Hfa Albuterol Sulfate | 209 | 228 | 61 | $13K |
| Furosemide Generic | 205 | 286 | 44 | $876 |
| Breo Ellipta Fluticasone/Vilanterol | 198 | 220 | 35 | $87K |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 188 | 190 | 85 | $2,449 |
| Fluticasone Propionate Generic | 154 | 269 | 60 | $3,345 |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 140 | 166 | 35 | $74K |
| Advair Hfa Fluticasone Propion/Salmeterol | 132 | 183 | 35 | $76K |
Brand drugs: - claims; generic drugs: 4,930 claims; opioid claims: 41.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Richard C Redman $165 ($165 in general payments such as food, travel and fees) from 5 companies. The largest payer was GlaxoSmithKline, LLC. with $53.21.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.